5,8-dibromoquinoxaline CAS 148231-12-3
| CAS No. | 148231-12-3 |
| Molecular Formula | C8H14Br2N2 |
| Molecular Weight | 298.02 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
Compared with other compounds in its class, the molecular weight of 298.02 g/mol gives 5,8-dibromoquinoxaline distinctive chromatographic separation conditions and mass-spectrometry parameter settings.
5,8-dibromoquinoxaline (CAS 148231-12-3) is a high-purity analytical reference standard with the molecular formula C8H14Br2N2 and a molecular weight of 298.02 g/mol.
Based on its molecular formula C8H14Br2N2, 5,8-dibromoquinoxaline contains a nitrile group, bromine substitution; these features give the compound characteristic molecular-ion distribution patterns in mass spectrometry. The molecular weight of 298.02 g/mol is directly relevant to the identification of the molecular ion in mass spectrometry. Nitrogen-containing functional groups confer excellent ionization efficiency in positive-ion electrospray (ESI) mode, making the compound well suited to LC-MS/MS analysis.
Recommended for analytical method development and validation; each product is supplied with a full Certificate of Analysis (COA) ensuring ISO 17034 metrological traceability.
The assigned purity is verified by mass-balance and quantitative NMR (qNMR) approaches, with the expanded uncertainty reported at a 95% confidence level (k=2). Batch homogeneity and stability are independently assessed for every lot.
Physical & Chemical Properties
| Molecular Formula | C8H14Br2N2 |
| Molecular Weight | 298.02 g/mol |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light, keep tightly closed to prevent evaporation |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 2.0 |
| CAS Registry Year (est.) | 1999 |
| Halogen Content | Br-containing |
| Nitrogen Atoms | 2 |
Related dibromoquinoxaline Standards
Recommended Standards
- 7-bromo-2-(bromomethyl)imidazo[1,2-a]pyridine (CAS 1379315-09-9)
- 3,8-dibromo-1,5-naphthyridine (CAS 154015-16-4)
- 8-bromo-2-(bromomethyl)imidazo[1,2-a]pyridine (CAS 1379311-03-1)
- 3,7-dibromo-1,5-naphthyridine (CAS 17965-72-9)
- Tert-butyl 10-oxo-8-oxa-2,11-diazaspiro[5.6]dodecane-2-carboxylate (CAS 1935503-30-2)
- (2-(4-Bromophenyl)-7-methylimidazo[1,2-a]pyridin-3-yl)methanamine (CAS 522651-97-4)
- (4-bromo-7-fluoro-2-methyl-1H-indol-3-yl) acetate (CAS 2628291-21-2)
- Imrecoxib (CAS 395683-14-4)
- 3-Methyl-1-(p-tolyl)cyclohexan-1-ol (CAS 149602-69-7)
- Pent-4-en-2-amine (CAS 31685-30-0)
- 4,6-Dibromo-2-(4-(tert-butyl)phenyl)benzo[d]oxazol-5-amine (CAS 637303-01-6)
- 1-(6-Bromo-5-methoxypyridin-3-yl)ethan-1-one (CAS 1256821-65-4)
- 2,3-dihydro-1H-1,5-naphthyridin-4-one (CAS 1211528-89-0)
- Glucagon Monohydrochloride (CAS 28270-04-4)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com